Safety and Immunogenicity of Two Doses of aH5N1 Vaccine in Adult and Elderly Subjects With and Without Immunosuppressive Conditions *aH5N1:Monovalent H5N1 Influenza Vaccine
Conditions:   Influenza, Human;   Flu, Human;   Flu, Avian;   Influenza;   Influenza A Virus, H5N1 SubtypeInterventions:   Biological: Novartis Investigational H5N1 vaccine;   Biological: Novartis Investigational H5N1 vaccine;   Biological: Novartis Seasonal Influenza Vaccine;   Biological: Novartis Seasonal Influenza VaccineSponsors:   Novartis;   Novartis VaccinesRecruiting - verified April 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 7, 2014 Category: Research Source Type: clinical trials